APO Research
Talk to an analyst

APO RESEARCH · REPORT

Nuclease

A Nuclease (also archaically known as nucleodepolymerase or polynucleotidase) is an enzyme capable of cleaving the phosphodiester bonds between nucleotides of nucleic acids.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

A Nuclease (also archaically known as nucleodepolymerase or polynucleotidase) is an enzyme capable of cleaving the phosphodiester bonds between nucleotides of nucleic acids.

Selected research

Industry Growth & Trends

Global Nuclease Industry Growth and Trends Forecast to 2032

28 December 2025119 pages

Choose your research edition.

Industry ResearchNuclease Industry Research Report 2026132 pages · $2,950 USDIndustry Growth & TrendsGlobal Nuclease Industry Growth and Trends Forecast to 2032119 pages · $3,450 USDMarket StructureGlobal Nuclease Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Nuclease Market Outlook and Growth Opportunities 2026203 pages · $4,250 USDMarket Analysis & ForecastGlobal Nuclease Market Analysis and Forecast 2026-2032203 pages · $4,950 USD

Market perspective

A Nuclease (also archaically known as nucleodepolymerase or polynucleotidase) is an enzyme capable of cleaving the phosphodiester bonds between nucleotides of nucleic acids.

The global well-known brands in Nuclease include New England Biolabs(14.61%), MercK(7.28%), Illumina(6.73%), Thermo Fisher Scientific(4.51%), Agilent Technologies(3.84%), Cytiva(2.99%), Roche(2.94%), Takara Bio(2.47%), C-LEcta(1.90%), Aldevron(1.72%), Lucigen(1.39%), Promega Corporation(1.26%), Qiagen(1.01%), Amicogen(0.60%), Codexis(0.51%), BBI Solution(0.31%) and Others(45.95%).

The application area of Nuclease includes Academic & Research Institutes, Biopharmaceutical, Hospitals & Diagnostic Centers and Other.

Read the full market overview

In terms of types, Nuclease can be divided into DNases and RNases.

On basis of geography, Nuclease is manufactured in North America, Europe, Japan and Korea.

Report Scope

This report provides a structured, data-driven view of the global Nuclease market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Nuclease market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Nuclease market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Nuclease.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Nuclease market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Nuclease Market by Company

New England Biolabs

MercK

Illumina

Thermo Fisher Scientific

Agilent Technologies

Cytiva

Roche

Takara Bio

C-LEcta

Aldevron

Lucigen

Promega Corporation

Qiagen

Amicogen

Codexis

BBI Solution

Nuclease Segment by Type

DNases

RNases

Nuclease Segment by Application

Academic & Research Institutes

Biopharmaceutical

Hospitals & Diagnostic Centers

Other

Nuclease Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nuclease market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Nuclease and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nuclease.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Nuclease manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Nuclease in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of DNases Table 2. Major Company of RNases Table 3. Global Nuclease Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Nuclease Sales by Type (2021-2026) & (K Units) Table 5. Global Nuclease Sales Market Share in Volume by Type (2021-2026) Table 6. Global Nuclease Sales by Type (2021-2026) & (US$ Million) Table 7. Global Nuclease Sales Market Share in Value by Type (2021-2026) Table 8. Global Nuclease Price by Type (2021-2026) & (USD/Unit) Table 9. Global Nuclease Sales by Type (2027-2032) & (K Units) Table 10. Global Nuclease Sales Market Share in Volume by Type (2027-2032) Table 11. Global Nuclease Sales by Type (2027-2032) & (US$ Million) Table 12. Global Nuclease Sales Market Share in Value by Type (2027-2032) Table 13. Global Nuclease Price by Type (2027-2032) & (USD/Unit) Table 14. North America Nuclease Sales by Type (2021-2026) & (K Units) Table 15. North America Nuclease Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Nuclease Sales by Type (2021-2026) & (K Units) Table 17. Europe Nuclease Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Nuclease Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Nuclease Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Nuclease Sales by Type (2021-2026) & (K Units) Table 21. Latin America Nuclease Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Nuclease Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Nuclease Sales by Type (2021-2026) & (US$ Million) Table 24. Nuclease Industry Trends Table 25. Nuclease Industry Drivers Table 26. Nuclease Industry Opportunities and Challenges Table 27. Nuclease Industry Restraints Table 28. Global Nuclease Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Nuclease Revenue Market Share by Company (2021-2026) Table 30. Global Nuclease Sales by Company (2021-2026) & (K Units) Table 31. Global Nuclease Sales Share by Company (2021-2026) Table 32. Global Nuclease Market Price by Company (2021-2026) & (USD/Unit) Table 33. Global Nuclease Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Nuclease Major Company Production Sites and Headquarters Table 35. Global Nuclease Company, Product Type & Application Table 36. Global Nuclease Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Nuclease by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Nuclease Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Nuclease Sales by Region (2021-2026) & (K Units) Table 41. Global Nuclease Sales Market Share in Volume by Region (2021-2026) Table 42. Global Nuclease Sales by Region (2021-2026) & (US$ Million) Table 43. Global Nuclease Sales Market Share in Value by Region (2021-2026) Table 44. Global Nuclease Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 45. Global Nuclease Sales by Region (2027-2032) & (K Units) Table 46. Global Nuclease Sales Market Share in Volume by Region (2027-2032) Table 47. Global Nuclease Sales by Region (2027-2032) & (US$ Million) Table 48. Global Nuclease Sales Market Share in Value by Region (2027-2032) Table 49. Global Nuclease Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2027-2032) Table 50. Global Nuclease Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Nuclease Sales by Application (2021-2026) & (K Units) Table 52. Global Nuclease Sales Market Share in Volume by Application (2021-2026) Table 53. Global Nuclease Sales by Application (2021-2026) & (US$ Million) Table 54. Global Nuclease Sales Market Share in Value by Application (2021-2026) Table 55. Global Nuclease Price by Application (2021-2026) & (USD/Unit) Table 56. Global Nuclease Sales by Application (2027-2032) & (K Units) Table 57. Global Nuclease Sales Market Share in Volume by Application (2027-2032) Table 58. Global Nuclease Sales by Application (2027-2032) & (US$ Million) Table 59. Global Nuclease Sales Market Share in Value by Application (2027-2032) Table 60. Global Nuclease Price by Application (2027-2032) & (USD/Unit) Table 61. North America Nuclease Sales by Application (2021-2026) & (K Units) Table 62. North America Nuclease Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Nuclease Sales by Application (2021-2026) & (K Units) Table 64. Europe Nuclease Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Nuclease Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Nuclease Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Nuclease Sales by Application (2021-2026) & (K Units) Table 68. Latin America Nuclease Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Nuclease Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Nuclease Sales by Application (2021-2026) & (US$ Million) Table 71. New England Biolabs Company Information Table 72. New England Biolabs Business Overview Table 73. New England Biolabs Nuclease Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 74. New England Biolabs Nuclease Product Portfolio Table 75. New England Biolabs Recent Development Table 76. MercK Company Information Table 77. MercK Business Overview Table 78. MercK Nuclease Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 79. MercK Nuclease Product Portfolio Table 80. MercK Recent Development Table 81. Illumina Company Information Table 82. Illumina Business Overview Table 83. Illumina Nuclease Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 84. Illumina Nuclease Product Portfolio Table 85. Illumina Recent Development Table 86. Thermo Fisher Scientific Company Information Table 87. Thermo Fisher Scientific Business Overview Table 88. Thermo Fisher Scientific Nuclease Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 89. Thermo Fisher Scientific Nuclease Product Portfolio Table 90. Thermo Fisher Scientific Recent Development Table 91. Agilent Technologies Company Information Table 92. Agilent Technologies Business Overview Table 93. Agilent Technologies Nuclease Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 94. Agilent Technologies Nuclease Product Portfolio Table 95. Agilent Technologies Recent Development Table 96. Cytiva Company Information Table 97. Cytiva Business Overview Table 98. Cytiva Nuclease Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 99. Cytiva Nuclease Product Portfolio Table 100. Cytiva Recent Development Table 101. Roche Company Information Table 102. Roche Business Overview Table 103. Roche Nuclease Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 104. Roche Nuclease Product Portfolio Table 105. Roche Recent Development Table 106. Takara Bio Company Information Table 107. Takara Bio Business Overview Table 108. Takara Bio Nuclease Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 109. Takara Bio Nuclease Product Portfolio Table 110. Takara Bio Recent Development Table 111. C-LEcta Company Information Table 112. C-LEcta Business Overview Table 113. C-LEcta Nuclease Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 114. C-LEcta Nuclease Product Portfolio Table 115. C-LEcta Recent Development Table 116. Aldevron Company Information Table 117. Aldevron Business Overview Table 118. Aldevron Nuclease Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 119. Aldevron Nuclease Product Portfolio Table 120. Aldevron Recent Development Table 121. Lucigen Company Information Table 122. Lucigen Business Overview Table 123. Lucigen Nuclease Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 124. Lucigen Nuclease Product Portfolio Table 125. Lucigen Recent Development Table 126. Promega Corporation Company Information Table 127. Promega Corporation Business Overview Table 128. Promega Corporation Nuclease Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 129. Promega Corporation Nuclease Product Portfolio Table 130. Promega Corporation Recent Development Table 131. Qiagen Company Information Table 132. Qiagen Business Overview Table 133. Qiagen Nuclease Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 134. Qiagen Nuclease Product Portfolio Table 135. Qiagen Recent Development Table 136. Amicogen Company Information Table 137. Amicogen Business Overview Table 138. Amicogen Nuclease Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 139. Amicogen Nuclease Product Portfolio Table 140. Amicogen Recent Development Table 141. Codexis Company Information Table 142. Codexis Business Overview Table 143. Codexis Nuclease Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 144. Codexis Nuclease Product Portfolio Table 145. Codexis Recent Development Table 146. BBI Solution Company Information Table 147. BBI Solution Business Overview Table 148. BBI Solution Nuclease Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 149. BBI Solution Nuclease Product Portfolio Table 150. BBI Solution Recent Development Table 151. North America Nuclease Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 152. North America Nuclease Sales by Country (2021-2026) & (K Units) Table 153. North America Nuclease Sales Market Share by Country (2021-2026) Table 154. North America Nuclease Sales Forecast by Country (2027-2032) & (K Units) Table 155. North America Nuclease Sales Market Share Forecast by Country (2027-2032) Table 156. North America Nuclease Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. North America Nuclease Market Size by Country (2021-2026) & (US$ Million) Table 158. North America Nuclease Market Share by Country (2021-2026) Table 159. North America Nuclease Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. North America Nuclease Market Share Forecast by Country (2027-2032) Table 161. Europe Nuclease Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 162. Europe Nuclease Sales by Country (2021-2026) & (K Units) Table 163. Europe Nuclease Sales Market Share by Country (2021-2026) Table 164. Europe Nuclease Sales Forecast by Country (2027-2032) & (K Units) Table 165. Europe Nuclease Sales Market Share Forecast by Country (2027-2032) Table 166. Europe Nuclease Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Europe Nuclease Market Size by Country (2021-2026) & (US$ Million) Table 168. Europe Nuclease Market Share by Country (2021-2026) Table 169. Europe Nuclease Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Europe Nuclease Market Share Forecast by Country (2027-2032) Table 171. Asia-Pacific Nuclease Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 172. Asia-Pacific Nuclease Sales by Country (2021-2026) & (K Units) Table 173. Asia-Pacific Nuclease Sales Market Share by Country (2021-2026) Table 174. Asia-Pacific Nuclease Sales Forecast by Country (2027-2032) & (K Units) Table 175. Asia-Pacific Nuclease Sales Market Share Forecast by Country (2027-2032) Table 176. Asia-Pacific Nuclease Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 177. Asia-Pacific Nuclease Market Size by Country (2021-2026) & (US$ Million) Table 178. Asia-Pacific Nuclease Market Share by Country (2021-2026) Table 179. Asia-Pacific Nuclease Market Size Forecast by Country (2027-2032) & (US$ Million) Table 180. Asia-Pacific Nuclease Market Share Forecast by Country (2027-2032) Table 181. Latin America Nuclease Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 182. Latin America Nuclease Sales by Country (2021-2026) & (K Units) Table 183. Latin America Nuclease Sales Market Share by Country (2021-2026) Table 184. Latin America Nuclease Sales Forecast by Country (2027-2032) & (K Units) Table 185. Latin America Nuclease Sales Market Share Forecast by Country (2027-2032) Table 186. Latin America Nuclease Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 187. Latin America Nuclease Market Size by Country (2021-2026) & (US$ Million) Table 188. Latin America Nuclease Market Share by Country (2021-2026) Table 189. Latin America Nuclease Market Size Forecast by Country (2027-2032) & (US$ Million) Table 190. Latin America Nuclease Market Share Forecast by Country (2027-2032) Table 191. Middle East and Africa Nuclease Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 192. Middle East and Africa Nuclease Sales by Country (2021-2026) & (K Units) Table 193. Middle East and Africa Nuclease Sales Market Share by Country (2021-2026) Table 194. Middle East and Africa Nuclease Sales Forecast by Country (2027-2032) & (K Units) Table 195. Middle East and Africa Nuclease Sales Market Share Forecast by Country (2027-2032) Table 196. Middle East and Africa Nuclease Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 197. Middle East and Africa Nuclease Market Size by Country (2021-2026) & (US$ Million) Table 198. Middle East and Africa Nuclease Market Share by Country (2021-2026) Table 199. Middle East and Africa Nuclease Market Size Forecast by Country (2027-2032) & (US$ Million) Table 200. Middle East and Africa Nuclease Market Share Forecast by Country (2027-2032) Table 201. Key Raw Materials Table 202. Raw Materials Key Suppliers Table 203. Nuclease Distributors List Table 204. Nuclease Customers List Table 205. Research Programs/Design for This Report Table 206. Authors List of This Report Table 207. Secondary Sources Table 208. Primary Sources List of Figures Figure 1. Nuclease Image Figure 2. Global Nuclease Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Nuclease Market Size (2021-2032) & (US$ Million) Figure 4. Global Nuclease Sales (2021-2032) & (K Units) Figure 5. DNases Image Figure 6. Global DNases Sales YoY Growth (2021-2032) & (K Units) Figure 7. RNases Image Figure 8. Global RNases Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Nuclease Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Nuclease Market Share by Type 2025 VS 2032 Figure 11. North America Nuclease Sales Market Share in Volume by Type in 2025 Figure 12. North America Nuclease Sales Market Share in Value by Type in 2025 Figure 13. Europe Nuclease Sales Market Share in Volume by Type in 2025 Figure 14. Europe Nuclease Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Nuclease Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Nuclease Sales Market Share in Value by Type in 2025 Figure 17. Latin America Nuclease Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Nuclease Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Nuclease Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Nuclease Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Nuclease Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Academic & Research Institutes Image Figure 24. Global Academic & Research Institutes Sales YoY Growth (2021-2032) & (K Units) Figure 25. Biopharmaceutical Image Figure 26. Global Biopharmaceutical Sales YoY Growth (2021-2032) & (K Units) Figure 27. Hospitals & Diagnostic Centers Image Figure 28. Global Hospitals & Diagnostic Centers Sales YoY Growth (2021-2032) & (K Units) Figure 29. Other Image Figure 30. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 31. Global Nuclease Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Nuclease Market Share by Application 2025 VS 2032 Figure 33. North America Nuclease Sales Market Share in Volume by Application in 2025 Figure 34. North America Nuclease Sales Market Share in Value by Application in 2025 Figure 35. Europe Nuclease Sales Market Share in Volume by Application in 2025 Figure 36. Europe Nuclease Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Nuclease Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Nuclease Sales Market Share in Value by Application in 2025 Figure 39. Latin America Nuclease Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Nuclease Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Nuclease Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Nuclease Sales Market Share in Value by Application in 2025 Figure 43. North America Nuclease Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. North America Nuclease Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Nuclease Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Nuclease Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Nuclease Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Europe Nuclease Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Nuclease Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Nuclease Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Nuclease Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Asia-Pacific Nuclease Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Nuclease Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Nuclease Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Nuclease Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Latin America Nuclease Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Nuclease Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Nuclease Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Nuclease Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Middle East and Africa Nuclease Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Nuclease Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Nuclease Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Nuclease Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Nuclease Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • DNases
  • RNases
Applications
  • Academic & Research Institutes
  • Biopharmaceutical
  • Hospitals & Diagnostic Centers
  • Other
Companies covered
  • New England Biolabs
  • MercK
  • Illumina
  • Thermo Fisher Scientific
  • Agilent Technologies
  • Cytiva
  • Roche
  • Takara Bio
  • C-LEcta
  • Aldevron
  • Lucigen
  • Promega Corporation
  • Qiagen
  • Amicogen
  • Codexis
  • BBI Solution

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Nuclease Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Nuclease Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Nuclease Market by Type
  6. 1.3.1 DNases
  7. 1.3.2 RNases
  8. 1.4 Global Nuclease Market Size by Type
  9. 1.4.1 Global Nuclease Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Nuclease Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Nuclease Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Nuclease Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Nuclease Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Nuclease Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Nuclease Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Nuclease Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Nuclease Industry Trends
  2. 2.2 Nuclease Industry Drivers
  3. 2.3 Nuclease Industry Opportunities and Challenges
  4. 2.4 Nuclease Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Nuclease Revenue (2021-2026)
  2. 3.2 Global Top Players by Nuclease Sales (2021-2026)
  3. 3.3 Global Top Players by Nuclease Price (2021-2026)
  4. 3.4 Global Nuclease Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Nuclease Major Company Production Sites & Headquarters
  6. 3.6 Global Nuclease Company, Product Type & Application
  7. 3.7 Global Nuclease Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Nuclease Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Nuclease Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Nuclease Tier 1, Tier 2, and Tier 3
4 Nuclease Regional Status and Outlook
  1. 4.1 Global Nuclease Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Nuclease Historic Market Size by Region
  3. 4.2.1 Global Nuclease Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Nuclease Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Nuclease Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Nuclease Forecasted Market Size by Region
  7. 4.3.1 Global Nuclease Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Nuclease Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Nuclease Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Nuclease by Application
  1. 5.1 Nuclease Market by Application
  2. 5.1.1 Academic & Research Institutes
  3. 5.1.2 Biopharmaceutical
  4. 5.1.3 Hospitals & Diagnostic Centers
  5. 5.1.4 Other
  6. 5.2 Global Nuclease Market Size by Application
  7. 5.2.1 Global Nuclease Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Nuclease Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Nuclease Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Nuclease Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Nuclease Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Nuclease Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Nuclease Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Nuclease Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 New England Biolabs
  2. 6.1.1 New England Biolabs Company Information
  3. 6.1.2 New England Biolabs Business Overview
  4. 6.1.3 New England Biolabs Nuclease Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 New England Biolabs Nuclease Product Portfolio
  6. 6.1.5 New England Biolabs Recent Developments
  7. 6.2 MercK
  8. 6.2.1 MercK Company Information
  9. 6.2.2 MercK Business Overview
  10. 6.2.3 MercK Nuclease Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 MercK Nuclease Product Portfolio
  12. 6.2.5 MercK Recent Developments
  13. 6.3 Illumina
  14. 6.3.1 Illumina Company Information
  15. 6.3.2 Illumina Business Overview
  16. 6.3.3 Illumina Nuclease Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Illumina Nuclease Product Portfolio
  18. 6.3.5 Illumina Recent Developments
  19. 6.4 Thermo Fisher Scientific
  20. 6.4.1 Thermo Fisher Scientific Company Information
  21. 6.4.2 Thermo Fisher Scientific Business Overview
  22. 6.4.3 Thermo Fisher Scientific Nuclease Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Thermo Fisher Scientific Nuclease Product Portfolio
  24. 6.4.5 Thermo Fisher Scientific Recent Developments
  25. 6.5 Agilent Technologies
  26. 6.5.1 Agilent Technologies Company Information
  27. 6.5.2 Agilent Technologies Business Overview
  28. 6.5.3 Agilent Technologies Nuclease Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Agilent Technologies Nuclease Product Portfolio
  30. 6.5.5 Agilent Technologies Recent Developments
  31. 6.6 Cytiva
  32. 6.6.1 Cytiva Company Information
  33. 6.6.2 Cytiva Business Overview
  34. 6.6.3 Cytiva Nuclease Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Cytiva Nuclease Product Portfolio
  36. 6.6.5 Cytiva Recent Developments
  37. 6.7 Roche
  38. 6.7.1 Roche Company Information
  39. 6.7.2 Roche Business Overview
  40. 6.7.3 Roche Nuclease Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Roche Nuclease Product Portfolio
  42. 6.7.5 Roche Recent Developments
  43. 6.8 Takara Bio
  44. 6.8.1 Takara Bio Company Information
  45. 6.8.2 Takara Bio Business Overview
  46. 6.8.3 Takara Bio Nuclease Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Takara Bio Nuclease Product Portfolio
  48. 6.8.5 Takara Bio Recent Developments
  49. 6.9 C-LEcta
  50. 6.9.1 C-LEcta Company Information
  51. 6.9.2 C-LEcta Business Overview
  52. 6.9.3 C-LEcta Nuclease Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 C-LEcta Nuclease Product Portfolio
  54. 6.9.5 C-LEcta Recent Developments
  55. 6.10 Aldevron
  56. 6.10.1 Aldevron Company Information
  57. 6.10.2 Aldevron Business Overview
  58. 6.10.3 Aldevron Nuclease Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Aldevron Nuclease Product Portfolio
  60. 6.10.5 Aldevron Recent Developments
  61. 6.11 Lucigen
  62. 6.11.1 Lucigen Company Information
  63. 6.11.2 Lucigen Business Overview
  64. 6.11.3 Lucigen Nuclease Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Lucigen Nuclease Product Portfolio
  66. 6.11.5 Lucigen Recent Developments
  67. 6.12 Promega Corporation
  68. 6.12.1 Promega Corporation Company Information
  69. 6.12.2 Promega Corporation Business Overview
  70. 6.12.3 Promega Corporation Nuclease Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Promega Corporation Nuclease Product Portfolio
  72. 6.12.5 Promega Corporation Recent Developments
  73. 6.13 Qiagen
  74. 6.13.1 Qiagen Company Information
  75. 6.13.2 Qiagen Business Overview
  76. 6.13.3 Qiagen Nuclease Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Qiagen Nuclease Product Portfolio
  78. 6.13.5 Qiagen Recent Developments
  79. 6.14 Amicogen
  80. 6.14.1 Amicogen Company Information
  81. 6.14.2 Amicogen Business Overview
  82. 6.14.3 Amicogen Nuclease Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Amicogen Nuclease Product Portfolio
  84. 6.14.5 Amicogen Recent Developments
  85. 6.15 Codexis
  86. 6.15.1 Codexis Company Information
  87. 6.15.2 Codexis Business Overview
  88. 6.15.3 Codexis Nuclease Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Codexis Nuclease Product Portfolio
  90. 6.15.5 Codexis Recent Developments
  91. 6.16 BBI Solution
  92. 6.16.1 BBI Solution Company Information
  93. 6.16.2 BBI Solution Business Overview
  94. 6.16.3 BBI Solution Nuclease Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 BBI Solution Nuclease Product Portfolio
  96. 6.16.5 BBI Solution Recent Developments
7 North America by Country
  1. 7.1 North America Nuclease Sales by Country
  2. 7.1.1 North America Nuclease Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Nuclease Sales by Country (2021-2026)
  4. 7.1.3 North America Nuclease Sales Forecast by Country (2027-2032)
  5. 7.2 North America Nuclease Market Size by Country
  6. 7.2.1 North America Nuclease Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Nuclease Market Size by Country (2021-2026)
  8. 7.2.3 North America Nuclease Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Nuclease Sales by Country
  2. 8.1.1 Europe Nuclease Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Nuclease Sales by Country (2021-2026)
  4. 8.1.3 Europe Nuclease Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Nuclease Market Size by Country
  6. 8.2.1 Europe Nuclease Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Nuclease Market Size by Country (2021-2026)
  8. 8.2.3 Europe Nuclease Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Nuclease Sales by Country
  2. 9.1.1 Asia-Pacific Nuclease Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Nuclease Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Nuclease Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Nuclease Market Size by Country
  6. 9.2.1 Asia-Pacific Nuclease Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Nuclease Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Nuclease Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Nuclease Sales by Country
  2. 10.1.1 South America Nuclease Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Nuclease Sales by Country (2021-2026)
  4. 10.1.3 South America Nuclease Sales Forecast by Country (2027-2032)
  5. 10.2 South America Nuclease Market Size by Country
  6. 10.2.1 South America Nuclease Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Nuclease Market Size by Country (2021-2026)
  8. 10.2.3 South America Nuclease Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Nuclease Sales by Country
  2. 11.1.1 Middle East and Africa Nuclease Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Nuclease Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Nuclease Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Nuclease Market Size by Country
  6. 11.2.1 Middle East and Africa Nuclease Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Nuclease Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Nuclease Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Nuclease Value Chain Analysis
  2. 12.1.1 Nuclease Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Nuclease Production Mode & Process
  7. 12.2 Nuclease Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Nuclease Distributors
  10. 12.2.3 Nuclease Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst